Gene expression profiling of advanced ovarian cancer: Characterization of a molecular signature involving fibroblast growth factor 2

Oncogene

Volumn 23, Issue 49, 2004, Pages 8171-8183

  De Cecco, Loris ^a,b,c   Marchionni, Luigi ^a   Gariboldi, Manuela ^b,c   Reid, James F ^a,c   Lagonigro, M Stefania ^b,c   Caramuta, Stefano ^b,c   Ferrario, Cristina ^b,c   Bussani, Erica ^b,c   Mezzanzanica, Delia ^b   Turatti, Fabio ^b   Delia, Domenico ^b   Daidone, Maria G ^b   Oggionni, Maria ^b   Bertuletti, Norma ^b   Ditto, Antonino ^b   Raspagliesi, Francesco ^b   Pilotti, Silvana ^b   Pierotti, Marco A ^b,c   Canevari, Silvana ^b   Schneider, Claudio ^a,b  

^a Laboratorio Nazionale CIB   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

Author keywords

Automated class discovery; Epithelial mesenchymal transition; Epithelial stromal interaction; Gene expression profiling; Ovarian cancer

Indexed keywords

COMPLEMENTARY DNA; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; SCLEROPROTEIN;

ADVANCED CANCER; ARTICLE; AUTOCRINE EFFECT; AUTOMATION; CANCER CELL CULTURE; CELL INTERACTION; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; DNA MICROARRAY; EPITHELIUM; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MESENCHYME; OVARY CANCER; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STROMA; TISSUE INTERACTION; GENE EXPRESSION PROFILING; GENETICS; OVARY TUMOR; PHYSIOLOGY; TUMOR CELL LINE;

FALLOPIA;

CELL LINE, TUMOR; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; RECEPTORS, FIBROBLAST GROWTH FACTOR;

EID: 7944231119     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207979     Document Type: Article

References (64)

1. Auersperg N, Maines-Bandiera SL, Dyck HG and Kruk PA. (1994). Lab. Invest., 71, 510-518.
2. Auersperg N, Wong AS, Choi KC, Kang SK and Leung PC. (2001). Endocr. Rev., 22, 255-288.
3. Aunoble B, Sanches R, Didier E and Bignon YJ. (2000). Int. J. Oncol., 16, 567-576.
4. Balli S, Fey MF, Hanggi W, Zwahlen D, Berclaz G, Dreher E and Aebi S. (2000). Eur. J. Cancer, 36, 2061-2068.
5. Bertrand V, Hudson C, Caillol D, Popovici C and Lemaire P. (2003). Cell, 115, 615-627.
6. Crickard K, Gross JL, Crickard U, Yoonessi M, Lele S, Herblin WF and Eidsvoog K. (1994). Gynecol. Oncol., 55, 277-284.
7. Darai E, Scoazec JY, Walker-Combrouze F, Mlika-Cabanne N, Feldmann G, Madelenat P and Potet F. (1997). Hum. Pathol., 28, 922-928.
8. Davies BR, Worsley SD and Ponder BA. (1998). Histopathology, 32, 69-80.
9. Di Blasio AM, Carniti C, Vigano P and Vignali M. (1995). J. Steroid. Biochem. Mol. Biol., 53, 375-379.
10. Dyck HG, Hamilton TC, Godwin AK, Lynch HT, Maines-Bandiera SL and Auersperg N. (1996). Int. J. Cancer, 69, 429-436.
11. Dysvik B and Jonassen I. (2001). Bioinformatics, 17, 369-370.
12. Feeley KM and Wells M. (2001). Histopathology, 38, 87-95.
13. Fujimoto J, Ichigo S, Hori M, Hirose R, Sakaguchi H and Tamaya T. (1997). Eur. J. Gynaecol. Oncol., 18, 349-352.
14. Greenlee RT, Hill-Harmon MB, Murray T and Thun M. (2001). CA Cancer J. Clin., 51, 15-36.
15. Holschneider CH and Berek JS. (2000). Semin. Surg. Oncol., 19, 3-10.
16. Hori A, Sasada R, Matsutani E, Naito K, Sakura Y, Fujita T and Kozai Y. (1991). Cancer Res., 51, 6180-6184.
17. Hosack DA, Dennis Jr G, Sherman BT, Lane HC and Lempicki RA. (2003). Genome Biol., 4, R70.
18. Hough CD, Cho KR, Zonderman AB, Schwartz DR and Morin PJ. (2001). Cancer Res., 61, 3869-3876.
19. Hough CD, Sherman-Baust CA, Pizer ES, Montz FJ, Im DD, Rosenshein NB, Cho KR, Riggins GJ and Morin PJ. (2000). Cancer Res., 60, 6281-6287.
20. Janda E, Lehmann K, Killisch I, Jechlinger M, Herzig M, Downward J, Beug H and Grunert S. (2002). J. Cell Biol., 156, 299-313.
21. Jazaeri AA, Yee CJ, Sotiriou C, Brantley KR, Boyd J and Liu ET. (2002). J. Natl. Cancer Inst., 94, 990-1000.
22. Karavanova ID, Dove LF, Resau JH and Perantoni AO. (1996). Development, 122, 4159-4167.
23. Kinsella MG, Tsoi CK, Jarvelainen HT and Wight TN. (1997). J. Biol. Chem., 272, 318-325.
24. Kodama J, Hashimoto I, Seki N, Kongo A, Yoshinouchi M, Okuda H and Kudo T. (2001). Anticancer Res., 21, 2983-2987.
25. Kruk PA, Maines-Bandiera SL and Auersperg N. (1990). Lab. Invest., 63, 132-136.
26. Kruk PA, Uitto VJ, Firth JD, Dedhar S and Auersperg N. (1994). Exp. Cell Res., 215, 97-108.
27. Liotta LA and Kohn EC. (2002). J. Natl. Cancer Inst., 94, 1113-1114.
28. Long CJ, Roth MR, Tasheva ES, Funderburgh M, Smit R, Conrad GW and Funderburgh JL. (2000). J. Biol. Chem., 275, 13918-13923.
29. Maines-Bandiera SL and Auersperg N. (1997). Int. J. Gynecol. Pathol., 16, 250-255.
30. Matei D, Graeber TG, Baldwin RL, Karlan BY, Rao J and Chang DD. (2002). Oncogene, 21, 6289-6298.
31. Matias-Guiu X and Prat J. (1998). Virchows Arch., 433, 103-111.
32. McShane LM, Radmacher MD, Freidlin B, Yu R, Li MC and Simon R. (2002). Bioinformatics, 18, 1462-1469.
33. Murdoch AD, Dodge GR, Cohen I, Tuan RS and Iozzo RV. (1992). J. Biol. Chem., 267, 8544-8557.
34. Obermair A, Speiser P, Reisenberger K, Ullrich R, Czerwenka K, Kaider A, Zeillinger R and Miksche M. (1998). Cancer Lett., 130, 69-76.
35. Ornitz DM and Marie PJ. (2002). Genes Dev., 16, 1446-1465.
36. Parrott JA, Nilsson E, Mosher R, Magrane G, Albertson D, Pinkel D, Gray JW and Skinner MK. (2001). Mol. Cell. Endocrinol., 175, 29-39.
37. Perantoni AO, Dove LF and Karavanova I. (1995). Proc. Natl. Acad. Sci. USA, 92, 4696-4700.
38. Plotnikov AN, Hubbard SR, Schlessinger J and Mohammadi M. (2000). Cell, 101, 413-424.
39. Plotnikov AN, Schlessinger J, Hubbard SR and Mohammadi M. (1999). Cell, 98, 641-650.
40. Powers CJ, McLeskey SW and Wellstein A. (2000). Endocr. Relat. Cancer, 7, 165-197.
41. Radmacher MD, McShane LM and Simon R. (2002). J. Comput. Biol., 9, 505-511.
42. Righetti SC, Perego P, Corna E, Pierotti MA and Zunino F. (1999). Cell Growth Differ., 10, 473-478.
43. Santala M, Simojoki M, Risteli J, Risteli L and Kauppila A. (1999). Clin. Cancer Res., 5, 4091-4096.
44. Schafer T, Zentgraf H, Zehe C, Brugger B, Bernhagen J and Nickel W. (2004). J. Biol. Chem., 279, 6244-6251.
45. Schaner ME, Ross DT, Ciaravino G, Sorlie T, Troyanskaya O, Diehn M, Wang YC, Duran GE, Sikic TL, Caldeira S, Skomedal H, Tu IP, Hernandez-Boussard T, Johnson SW, O'Dwyer PJ, Fero MJ, Kristensen GB, Borresen-Dale AL, Hastie T, Tibshirani R, van de RM, Teng NN, Longacre TA, Botstein D, Brown PO and Sikic BI. (2003). Mol. Biol. Cell, 14, 4376-4386.
46. Schlessinger J, Plotnikov AN, Ibrahimi OA, Eliseenkova AV, Yeh BK, Yayon A, Linhardt RJ and Mohammadi M. (2000). Mol. Cell, 6, 743-750.
47. Schwartz DR, Kardia SL, Shedden KA, Kuick R, Michailidis G, Taylor JM, Misek DE, Wu R, Zhai Y, Darrah DM, Reed H, Ellenson LH, Giordano TJ, Fearon ER, Hanash SM and Cho KR. (2002). Cancer Res., 62, 4722-4729.
48. Schwartz DR, Wu R, Kardia SL, Levin AM, Huang CC, Shedden KA, Kuick R, Misek DE, Hanash SM, Taylor JM, Reed H, Hendrix N, Zhai Y, Fearon ER and Cho KR. (2003). Cancer Res., 63, 2913-2922.
49. Sheng G, dos RM and Stern CD. (2003). Cell, 115, 603-613.
50. Sherman-Baust CA, Weeraratna AT, Rangel LB, Pizer ES, Cho KR, Schwartz DR, Shock T and Morin PJ. (2003). Cancer Cell, 3, 377-386.
51. Shridhar V, Lee J, Pandita A, Iturria S, Avula R, Staub J, Morrissey M, Calhoun E, Sen A, Kalli K, Keeney G, Roche P, Cliby W, Lu K, Schmandt R, Mills GB, Bast RCJ, James CD, Couch FJ, Hartmann LC, Lillie J and Smith DI. (2001). Cancer Res., 61, 5895-5904.
52. Simojoki M, Santala M, Risteli J and Kauppila A. (2001). Gynecol. Oncol., 82, 110-115.
53. Steele IA, Edmondson RJ, Bulmer JN, Bolger BS, Leung HY and Davies BR. (2001). Oncogene, 20, 5878-5887.
54. Strutz F, Zeisberg M, Ziyadeh FN, Yang CQ, Kalluri R, Muller GA and Neilson EG. (2002). Kidney Int., 61, 1714-1728.
55. Sundfeldt K, Piontkewitz Y, Ivarsson K, Nilsson O, Hellberg P, Brännström M, Janson PO, Enerbäck S and Hedin L. (1997). M. J. Cancer, 74, 275-280.
56. Taverna S, Ghersi G, Ginestra A, Rigogliuso S, Pecorella S, Alaimo G, Saladino F, Dolo V, Dell'Era P, Pavan A, Pizzolanti G, Mignatti P, Presta M and Vittorelli ML. (2003). J. Biol. Chem., 278, 51911-51919.
57. Thiery JP. (2002). Nat. Rev. Cancer, 2, 442-454.
58. Tonin PN, Hudson TJ, Rodier F, Bossolasco M, Lee PD, Novak J, Manderson EN, Provencher D and Mes-Masson AM. (2001). Oncogene, 20, 6617-6626.
59. Tsao SW, Mok CH, Knapp RC, Oike K, Muto MG, Welch WR, Goodman HM, Sheets EE, Berkowitz RS and Lau CC. (1993). Gynecol. Oncol., 48, 5-10.
60. Valve E, Martikainen P, Seppanen J, Oksjoki S, Hinkka S, Anttila L, Grenman S, Klemi P and Harkonen P. (2000). Int. J. Cancer, 88, 718-725.
61. Van Niekerk CC, Ramaekers FCS, Hanselaar AGJM, Aldeweireldt J and Poels LG. (1993). Am. J. Pathol., 142, 157-177.
62. von Heydebreck A, Huber W, Poustka A and Vingron M. (2001). Bioinformatics, 17, S107-S114.
63. Walsh FS and Doherty P. (1997). Annu. Rev. Cell Dev. Biol., 13, 425-456.
64. Welsh JB, Zarrinkar PP, Sapinoso LM, Kern SG, Behling CA, Monk BJ, Lockhart DJ, Burger RA and Hampton GM. (2001). Proc. Natl Acad. Sci. USA, 98, 1176-1181.